Virtu Financial’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
Other funds holding ACAD
BBA
Virtu Financial's ACAD Position: Q3 2026 in Review
Virtu Financial opened a new position in Acadia Pharmaceuticals (ACAD) in Q3 2026: 14,678 shares worth $296K. The stake represents 0.01% of the portfolio and ranks #787 among its holdings. This is a return to the name: Virtu Financial previously reported a position in ACAD as recently as Q3 2025.
Virtu Financial first reported a position in ACAD in Q4 2018 and has held it in 12 quarters since. The position peaked at $1.66M in Q3 2019. 350 funds tracked by Wall St. Rank hold ACAD as of Q3 2026.
- Virtu Financial held 14,678 shares of Acadia Pharmaceuticals worth $296K as of Q3 2026.
- Acadia Pharmaceuticals was a new Virtu Financial position in Q3 2026.
- Acadia Pharmaceuticals made up 0.01% of Virtu Financial's portfolio in Q3 2026, its #787 holding.
- Virtu Financial first reported a position in Acadia Pharmaceuticals in Q4 2018 and has held it in 12 quarters since.
- Virtu Financial's Acadia Pharmaceuticals position peaked at $1.66M in Q3 2019.
- 350 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q3 2026.
Based on Virtu Financial's 13F filing for Q3 2026, filed 17 Nov 2026.